GATA4 transgenic mice as an in vivo model of congenital heart disease

International Journal of Molecular Medicine

Volumn 35, Issue 6, 2015, Pages 1545-1553

  Han, Hua ^a   Chen, Yu ^a   Liu, Gang ^a   Han, Zengqiang ^a   Zhao, Zhou ^a   Tang, Yin ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Atrial septal defect; Congenital heart disease; GATA4; Transgenic mouse

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MYOSIN HEAVY CHAIN ALPHA; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR GATA 6; TRANSCRIPTION FACTOR NKX2.5; TRANSCRIPTION FACTOR TBX5; TROPONIN C; GATA4 PROTEIN, HUMAN; GATA4 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DNA SEQUENCE; ECHOCARDIOGRAPHY; GENE EXPRESSION; GENE TARGETING; GENETIC STABILITY; GENOTYPE; HEART ATRIUM SEPTUM; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE WALL; HEART VENTRICLE SIZE; HETEROZYGOTE; IN VIVO STUDY; M MODE ECHOCARDIOGRAPHY; MOUSE; MOUSE MODEL; NEWBORN; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY VALVE STENOSIS; REAL TIME POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; TWO DIMENSIONAL ECHOCARDIOGRAPHY; WESTERN BLOTTING; WILD TYPE; AMINO ACID SUBSTITUTION; ANIMAL; DISEASE MODEL; ELECTROCARDIOGRAPHY; GENETICS; HEART SEPTUM DEFECT; HUMAN; METABOLISM; MISSENSE MUTATION; PATHOLOGY; PATHOPHYSIOLOGY;

AMINO ACID SUBSTITUTION; ANIMALS; DISEASE MODELS, ANIMAL; ELECTROCARDIOGRAPHY; GATA4 TRANSCRIPTION FACTOR; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; MICE; MUTATION, MISSENSE;

EID: 84928403271     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2015.2178     Document Type: Article

References (31)

1. Bentham J and Bhattacharya S: Genetic mechanisms controlling cardiovascular development. Ann NY Acad Sci 1123: 10-19, 2008
2. Molkentin JD, Lin Q, Duncan SA and Olson EN: Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev 11: 1061-1072, 1997
3. Brunskill EW, Witte DP, Yutzey KE and Potter SS: Novel cell lines promote the discovery of genes involved in early heart development. Dev Biol 235: 507-520, 2001
4. Temsah R and Nemer M: GATA factors and transcriptional regulation of cardiac natriuretic peptide genes. Regul Pept 128: 177-185, 2005
5. Sarkozy A, Conti E, Neri C, D'Agostino R, Digilio MC, Esposito G, Toscano A, Marino B, Pizzuti A and Dallapiccola B: Spectrum of atrial septal defects associated with mutations of NKX2.5 and GATA4 transcription factors. J Med Genet 42: e16, 2005
6. Garg V, Kathiriya IS, Barnes R, et al: GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 424: 443-447, 2003
7. Christoforou N, Chellappan M, Adler AF, Kirkton RD, Wu T, Addis RC, Bursac N and Leong KW: Transcription factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogramming. PLoS One 8: e63577, 2013
8. Dodou E, Verzi MP, Anderson JP, Xu SM and Black BL: Mef2c is a direct transcriptional target of ISL1 and GATA factors in the anterior heart field during mouse embryonic development. Development 131: 3931-3942, 2004
9. Chen Y, Han ZQ, Yan WD, Tang CZ, Xie JY, Chen H and Hu DY: A novel mutation in GATA4 gene associated with dominant inherited familial atrial septal defect. J Thorac Cardiovasc Surg 140: 684-687, 2010
10. Xiang R, Fan LL, Huang H, Cao BB, Li XP, Peng DQ and Xia K: A novel mutation of GATA4 (K319E) is responsible for familial atrial septal defect and pulmonary valve stenosis. Gene 534: 320-323, 2014
11. Garg V, Kathiriya IS, Barnes R, Schluterman MK, King IN, Butler CA, Rothrock CR, Eapen RS, Hirayama-Yamada K, Joo K, Matsuoka R, Cohen JC and Srivastava D: GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 424: 443-447, 2003
12. Maitra M, Schluterman MK, Nichols HA, Richardson JA, Lo CW, Srivastava D and Garg V: Interaction of Gata4 and Gata6 with Tbx5 is critical for normal cardiac development. Dev Biol 326: 368-377, 2009
13. Laforest B and Nemer M: GATA5 interacts with GATA4 and GATA6 in outflow tract development. Dev Biol 358: 368-378, 2011
14. Rajagopal SK, Ma Q, Obler D, et al: Spectrum of heart disease associated with murine and human GATA4 mutation. J Mol Cell Cardiol 43: 677-685, 2007
15. Misra C, Sachan N, McNally CR, Koenig SN, Nichols HA, Guggilam A, Lucchesi PA, Pu WT, Srivastava D and Garg V: Congenital heart disease-causing Gata4 mutation displays functional deficits in vivo. PLoS Genet 8: e1002690, 2012
16. Tang Y, Han Z, Han H and Chen Y: Mechanism involved in the familial atrial septal defects caused by GATA-4 M310V single gene mutation. China Circ J 3: 211-214, 2013 (In Chinese)
17. Ballester M, Castelló A, Ibáñez E, Sánchez A and Folch JM: Real-time quantitative PCR-based system for determining transgene copy number in transgenic animals. Biotechniques 37: 610-613, 2004
18. Nemer G, Fadlalah F, Usta J, Nemer M, Dbaibo G, Obeid M and Bitar F: A novel mutation in the GATA4 gene in patients with Tetralogy of Fallot. Hum Mutat 27: 293-294, 2006
19. Zeisberg EM, Ma Q, Juraszek AL, Moses K, Schwartz RJ, Izumo S and Pu WT: Morphogenesis of the right ventricle requires myocardial expression of Gata4. J Clin Invest 115: 1522-1531, 2005
20. Pu WT, Ishiwata T, Juraszek AL, Ma Q and Izumo S: GATA4 is a dosage-sensitive regulator of cardiac morphogenesis. Dev Biol 275: 235-244, 2004
21. McBride K and Nemer M: Regulation of the ANF and BNP promoters by GATA factors: Lessons learned for cardiac transcription. Can J Physiol Pharmacol 79: 673-681, 2001
22. Molkentin JD, Kalvakolanu DV and Markham BE: Transcription factor GATA-4 regulates cardiac muscle-specific expression of the alpha-myosin heavy-chain gene. Mol Cell Biol 14: 4947-4957, 1994
23. Morin S, Charron F, Robitaille L and Nemer M: GATA-dependent recruitment of MEF2 proteins to target promoters. EMBO J 19: 2046-2055, 2000
24. Ip HS, Wilson DB, Heikinheimo M, Tang Z, Ting CN, Simon MC, Leiden JM and Parmacek MS: The GATA-4 transcription factor transactivates the cardiac muscle-specific troponin C promoter-enhancer in nonmuscle cells. Mol Cell Biol 14: 7517-7526, 1994
25. Zhao R, Watt AJ, Battle MA, Li J, Bondow BJ and Duncan SA: Loss of both GATA4 and GATA6 blocks cardiac myocyte differentiation and results in acardia in mice. Dev Biol 317: 614-619, 2008
26. Jay PY, Harris BS, Maguire CT, Buerger A, Wakimoto H, Tanaka M, Kupershmidt S, Roden DM, Schultheiss TM, O'Brien TX, Gourdie RG, Berul CI and Izumo S: Nkx2-5 mutation causes anatomic hypoplasia of the cardiac conduction system. J Clin Invest 113: 1130-1137, 2004
27. Terada R, Warren S, Lu JT, Chien KR, Wessels A and Kasahara H: Ablation of Nkx2-5 at mid-embryonic stage results in premature lethality and cardiac malformation. Cardiovasc Res 91: 289-299, 2011
28. Takeda M, Briggs LE, Wakimoto H, Marks MH, Warren SA, Lu JT, Weinberg EO, Robertson KD, Chien KR and Kasahara H: Slow progressive conduction and contraction defects in loss of Nkx2-5 mice after cardiomyocyte terminal differentiation. Lab Invest 89: 983-993, 2009
29. Schlesinger J, Schueler M, Grunert M, Fischer JJ, Zhang Q, Krueger T, Lange M, Tönjes M, Dunkel I and Sperling SR: The cardiac transcription network modulated by Gata4, Mef2a, Nkx2.5, Srf, histone modifications, and microRNAs. PLoS Genet 7: e1001313, 2011
30. Yamagishi H, Yamagishi C, Nakagawa O, Harvey RP, Olson EN and Srivastava D: The combinatorial activities of Nkx2.5 and dHAND are essential for cardiac ventricle formation. Dev Biol 239: 190-203, 2001
31. Bruneau BG, Nemer G, Schmitt JP, Charron F, Robitaille L, Caron S, Conner DA, Gessler M, Nemer M, Seidman CE, Seidman JG: A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell 106: 709-721, 2001.